Accrued expenses consisted of the following (in thousands):
September 30,2024
December 31,2023
Accrued pre-clinical and clinical costs
$
1,628
1,449
Accrued product development costs
1,671
745
Accrued license costs
1,625
4,825
Accrued compensation
1,823
2,326
Accrued administrative costs
429
343
Accrued interest
—
1,342
Total
7,176
11,030
No definition available.
Tabular disclosure of the components of accrued liabilities.